PMC:7696151 / 14986-15248 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"414","span":{"begin":192,"end":200},"obj":"Species"},{"id":"418","span":{"begin":188,"end":191},"obj":"Species"},{"id":"433","span":{"begin":85,"end":88},"obj":"Chemical"},{"id":"434","span":{"begin":90,"end":101},"obj":"Chemical"},{"id":"435","span":{"begin":107,"end":117},"obj":"Chemical"}],"attributes":[{"id":"A414","pred":"tao:has_database_id","subj":"414","obj":"Tax:9606"},{"id":"A418","pred":"tao:has_database_id","subj":"418","obj":"Tax:12721"},{"id":"A433","pred":"tao:has_database_id","subj":"433","obj":"MESH:D006886"},{"id":"A434","pred":"tao:has_database_id","subj":"434","obj":"MESH:D006918"},{"id":"A435","pred":"tao:has_database_id","subj":"435","obj":"MESH:D016049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tandard antiretroviral therapy [23]. These results suggested that the combination of HCQ, hydroxyurea, and didanosine could be a valid alternative to the highly active commercial HAART in HIV-patients. Nonetheless, these latter studies have some limitations, suc"}

{"project":"LitCovid-sentences","denotations":[{"id":"T116","span":{"begin":37,"end":201},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"tandard antiretroviral therapy [23]. These results suggested that the combination of HCQ, hydroxyurea, and didanosine could be a valid alternative to the highly active commercial HAART in HIV-patients. Nonetheless, these latter studies have some limitations, suc"}